Introduction
One of the major side effects of irradiation therapy for lung cancer is the development of pulmonary fibrosis. 1, 2 The mechanism by which pulmonary fibrosis develops is unknown, but it is thought to involve increased synthesis of transforming growth factor-beta (TGF-b) at sites of lung damage. [3] [4] [5] Recruitment of macrophages and fibroblasts is associated with collagen deposition and leads to pulmonary fibrosis. [3] [4] [5] Clinical studies have demonstrated that patients who have increased plasma levels of TGF-b during radiotherapy have a higher risk of pulmonary fibrosis. 6, 7 The cells responsible for increased levels of TGF-b are unknown. It is not known whether those cells [3] [4] [5] damaged by irradiation or secondary migrating cells in response to irradiation injury produce the elevated TGF-b. The kinetics of repair of cells for each of several phenotypes after damage by irradiation is also unknown. To gain a better understanding of the pathophysiology of pulmonary irradiation fibrosis, we previously investigated which cells were damaged by irradiation and measured the recruitment of fibroblasts and macrophages into damaged areas. 8 Intratracheal (IT) administration of the manganese superoxide dismutase (MnSOD) transgene by either plasmid or adenoviral vectors has been shown to decrease both early and late side effects of ionizing irradiation in the mouse lung. 9, 10 MnSOD-plasmid/ liposome (PL) treatment has been associated with a decrease in irradiation-induced early elevation of mRNA for tumor necrosis factor-alpha (TNF-a), TGF-b, interleukin-1 (IL-l), as well as a decrease in late elevation of TGF-b. 11 Late elevations have been associated with the appearance of organizing alveolitis/fibrosis and decreased survival. 12, 13 Recent studies have demonstrated that IT administration of hemagglutinin (HA) epitopetagged MnSOD (HA-MnSOD) showed significant transgene uptake in pulmonary epithelial and endothelial cells, while intravenous administration resulted in enhanced endothelial cell expression. 8 HA-MnSOD-PL treatment decreased bromodeoxyuridine (BrdU)-detectable proliferation of cells in fibrotic areas at day 100 in sites of pulmonary fibrosis. 8 Upregulation of HAMnSOD in the mouse lung prior to irradiation was associated with decreased endothelial cell upregulation of vascular cell adhesion molecule (VCAM-1) and intracellular adhesion molecule (ICAM-1) at day 100, the time of development of organizing alveolitis/ fibrosis. 8 Previously, we had demonstrated that IT injections of 250 or 500 mg of MnSOD-PL would protect the lung from irradiation. 8 In the present study, we determined MnSOD biochemical activity associated with IT injections of MnSOD-PL in order to see if there was a minimal effective plasmid dose that correlated with radioprotection. Using epitope-tagged HA-MnSOD, we determined the duration of expression of immunohistologically and biochemically elevated transgene product in whole lung and in each of several cell phenotypes. We measured the kinetics of disappearance of HA-MnSOD within subpopulations of pulmonary cells. The results demonstrated elevation of MnSOD biochemical activity in whole lung for 4 days after IT injection, and cell phenotype specific patterns of disappearance of detectable epitope-tagged MnSOD gene product with persistence in endothelial cells and fibroblastic interstitial cells of the lung. The sustained increase in biochemical activity associated with transgene product for 2 days after IT administration supports an alternate-day administration schedule for pulmonary radioprotection during clinical protocols of fractionated radiotherapy.
Results
Persistence of biochemically active HA-MnSOD in mouse lung for 4 days after administration Figure 1a demonstrates a dose-response curve of weight of plasmid delivered in a constant 75 ml volume to C57 BL/6NHsd mice, with subgroups killed at 1,2,3 or 4 days after administration with total biochemical activity measured. The results that show doses as low as 10 mg of plasmid demonstrated a significant increase in biochemically active MnSOD in the lung at day 1. In contrast, mice that received empty liposomes showed no increase in biochemical activity at this time point. There was an increase in biochemical activity with doses up to 1000 mg. However, there was no further increase in MnSOD biochemical activity above doses of 100 mg of plasmid DNA. There was approximately a 50% decrease in MnSOD activity 24 h after injection. The increase in MnSOD activity persisted for all 4 days. For mice injected with 1000 mg MnSOD plasmid DNA, there was a more rapid decrease in MnSOD biochemical activity. Figure 1b shows the results with mice that were each given each of several doses of HA-MnSOD plasmid weight in a constant 75 ml liposome volume, and followed 24 h later with 20 Gy irradiation to both lungs. Mice were killed at several time points over 4 days after injection. In this experiment, 1 day represents 24 h after administration of HA-MnSOD-PL, which was the same day as irradiation. As shown in Figure 1b , mice injected with doses as low as 10 mg plasmid in 75 ml of liposomes demonstrated a significant increase in MnSOD biochemical activity at day 1 (the day of irradiation). At day 2, there was approximately a 50% decrease in MnSOD activity in the non-irradiated MnSOD-PL-injected mice (Figure 1a ). In contrast, at days 3 and 4, irradiated mice exhibited persistently increased MnSOD activity, which we hypothesized was attributable to non-epitope-tagged MnSOD murine endogenous MnSOD levels at 2 or 3 days following irradiation.
Persistence of HA-MnSOD in murine pulmonary cells varies with cell phenotype
To determine whether persistence of increased MnSOD biochemical activity in lungs of HA-MnSOD-treated mice was attributable to endogenous murine MnSOD biochemical activity, we measured the kinetics of disappearance of the transgene product HA-MnSOD in several subpopulations of pulmonary cells. Broncheoalveolar macrophages (BAMs) were separated according to bronchial lavage methodology. Pulmonary endothelial cells and alveolar type-II (AT-II) cells were isolated as described in the Methods. The remaining cells comprising fibroblasts and interstitial cells were cultured according to previously published methods. 8, 9, 14 Each cell population was assayed 24 h after separation and Figure 1 Time course of increased MnSOD biochemical activity in the whole lung of C57BL/6NHsd mice intratracheally injected with HAMnSOD-PL. C57BL/6NHsd mice were injected with 0, 10, 100, 250, 500 or 1000 mg of plasmid DNA in the constant volume of 75 ml of liposomes. The mice were killed at 1, 2, 3 or 4 days after injection (a). Other mice IT injected, as described above, were irradiated the next day to 20 Gy to the pulmonary cavity (b). The mice were killed immediately after or at 1, 2 or 3 days after irradiation (corresponding to day 1, 2, 3 or 4, after MnSOD-PL delivery). Lungs were removed, frozen in liquid nitrogen, and MnSOD biochemical activity determined. Units are the mean 7 s.e.m. of 10 mice per time point. (*Significant difference from 0.0 mg control day 1) (Po0.05). A difference in cell phenotype dependent kinetics of disappearance of HA from different cell compartments was also observed following 20 Gy irradiation (Figure 3 ). At days 3 and 4 (corresponding to days 2 and 3, respectively, following irradiation in this irradiated group), there was a decrease in HA expression in BAM cells (Figure 3a) and AT-II cells (Figure 3b ). This time course was similar to that detected in non-irradiated mice (Figure 2a and b, respectively) . Following irradiation there was persistent HA expression detected in pulmonary endothelial cells ( Figure 3c ) and pulmonary interstitial cells (Figure 3d ). Persistent expression past day 3 was also detected in non-irradiated endothelial cells and pulmonary interstitial cells ( Figure 2c and d, respectively).
Calculation of differential cell population specific biochemical activity
The relative biochemical activity in units of MnSOD for each of four daily time points relative to each plasmid dose is shown for sub-populations of BAMs, endothelial cells, AT-II cells, and interstitial cells (Table 1) . Expression of HA-MnSOD was detectable in all cell compartments. Based upon the published percent of rat lung cells of each cell phenotype 15 and the percent HA-positive cells in whole lung, we calculated the percent of lung cells of each phenotype that were positive for the HA epitope. Based upon this figure, we calculated the relative percent increase in MnSOD biochemical activity attributable to each cell phenotype. These results indicated that the level of increase in MnSOD biochemical activity in BAM cells and AT-II cells decreased after day 2. However, interstitial and endothelial cell expression remained high in irradiated and non-irradiated mice. While we detected an increase in total MnSOD biochemical activity following irradiation, we did not observe significant changes in the percent of cells expressing HA following irradiation. Increased expression of the HA-MnSOD transgene in a subset of cells within the lung may have contributed to the damageresponse or might have been altered by the irradiation Figure 2 Cell phenotype specific kinetics of disappearance of detectable HA-MnSOD expression in non-irradiated mouse lung. C57BL/6NHsd mice were injected with HA-MnSOD-PL containing 0, 250 or 500 mg of plasmid DNA. The mice were killed at day 1, 2, 3 or 4 after injection and the different cell compartments were isolated as described in the Methods. BAMs 
Discussion
Previously, we have demonstrated that IT injections of MnSOD-PL or an adenovirus containing the human MnSOD transgene protects the lungs from irradiationinduced damage.
9-12 However, we do not know which cell phenotype(s) are necessary for protection. Development of pulmonary fibrosis is a complex process involving the pulmonary endothelial cells, macrophages, fibroblasts, and cells originating in the bone marrow. [3] [4] [5] 8 To obtain evidence as to which cell may be protected during irradiation, we injected HA-MnSOD-PL intratracheally and killed the mice 1-4 days later. The different cell compartments were isolated and examined immunohistochemically for HA expression to determine HA-MnSOD uptake, and whether expression was specific for one cell type in preference to the other cell types. Preferential uptake of MnSOD may provide answers as to which cells need protection during radiation treatments.
In the present studies, mice were IT injected with HA-MnSOD-PL, and several cell phenotypes of the lung were separated and isolated at different time points following injection. Cells in each compartment were stained with an antibody to HA and the percent of positive cells calculated. Expression of HA was identified in all cell compartments of the lung with no unique pattern of uptake by one specific cell type. Thus, IT injection of HA-MnSOD-PL resulted in detectable transgene expression in all cell types tested.
The present studies demonstrated that significant elevation of biochemical activity of HA-MnSOD is persistent in the mouse lung following IT administration of HA-MnSOD-PL for 48 h at concentrations of 10, 100, 250 or 500 mg of plasmid DNA (Figure 1 ). Mice that were injected with the highest dose of plasmid DNA (1000 mg) demonstrated a more rapid relative loss of MnSOD biochemical activity, which reached background levels The calculation of relative levels of MnSOD biochemical activity in different mouse pulmonary cell types: C57BL/6NHsd mice were IT injected with MnSOD-PL at concentrations of 0, 250 or 500 mg of plasmid DNA. Half of the mice were irradiated to 20 Gy to the pulmonary cavity 24 h later. Subgroups of mice were killed 1, 2, 3 or 4 days after injection of MnSOD-PL. In irradiated mice, day 1 was immediately after irradiation. The different cell types were isolated as described in the Methods and stained for HA expression using an FITC-conjugated anti-HA monoclonal antibody. The percent of cells expressing HA was determined for each cell type 1 day after injection. Based upon published data for the percent of total lung cells of each type in the rat lung, 15 the percent of each type of mouse lung cell expressing HA was determined. Using this number we calculated the percent contribution for each cell compartment towards the total increase in MnSOD biochemical activity due to expression of the HA-MnSOD transgene. (Figure 1) . The decreased levels of MnSOD biochemical activity following injection of 1000 mg of MnSOD plasmid DNA may have resulted from plasmid overload, interference, or decreased endogenous murine MnSOD expression as a reactive cellular process to high transgene levels. [16] [17] [18] Further studies will be required to test these hypotheses. The data suggest that the protective effects of MnSOD-PL injections may be optimal at lower plasmid doses. The present results confirm and extend our prior studies demonstrating that RNA for the MnSOD human transgene was detectable in mouse lungs for 2 days after IT injection. 9 The present studies also demonstrate that transgene biochemical activity persisted longer than that detectable by measuring mRNA by nested reverse transcriptase-polymerase chain reaction (RT-PCR). 9 Thus, the present, more sensitive biochemical technique confirms that successful administration of MnSOD-PL every second day during fractionated irradiation may be adequate for fractionated radiotherapy protocols. In addition, significantly increased MnSOD expression was detected in all cell phenotypes for only 2 days following IT injection ( Figure  1 ). This suggests that MnSOD-PL administration during fractionated radiotherapy should occur every second day in order to cover of all cells during radiation treatments. These data have been obtained from our experience in a mouse model. Additional studies will be performed during a phase II/III clinical trial to document that MnSOD-PL administration every second day provides radioprotection of the lungs in human lung cancer patients.
The present studies showed that 20 Gy irradiation significantly increased MnSOD expression at days 3 and 4 after HA-MnSOD injection of 250, 500 or 1000 mg of plasmid DNA, which corresponded to 2 and 3 days after irradiation. By measuring HA-MnSOD expression in irradiated mice compared to control mice, there were no changes in the kinetics of disappearance or in the percent of cells expressing the human HA-MnSOD transgene (Figure 2) . Thus, the increased MnSOD expression in irradiated mice was the result of increased endogenous murine MnSOD biochemical activity. Previous data indicated that irradiation results in increased endogenous MnSOD-mRNA as well as increased MnSOD biochemical activity following irradiation. 19, 20 Ionizing irradiation induces expression of NFk-B, and its activation of the promoter for the MnSOD gene may be the mechanism of increased endogenous MnSOD expression. 21, 22 Administration of HA-MnSOD-PL in previous studies was as protective as non-tagged MnSOD with respect to decreased irradiation relative to organizing alveolitis and persistent biochemical activity. 8 The present results confirm previous studies and establish that the epitope tag did not significantly alter the radioprotective properties of the MnSOD transgene.
Differential expression of epitope-tagged MnSOD was found between different cell populations in the lung. Endothelial cells showed persistence for 2 days longer than BAM cells or AT-II cells (Table 1) (Figure 2) . The reasons for this difference are unknown. Endothelial cells may express epitope-tagged transgene for longer durations. In vitro studies (of transfected cells in culture for study of the duration of detection of mRNA and protein) are in progress to confirm this hypothesis. Alternatively, it is possible that our use of different techniques for culture of endothelial cells (compared to BAM cells and AT-II cells relative to fibroblasts) facilitated an enhanced retention of a subpopulation of endothelial cells with positive epitope-tag MnSOD expression. Other studies comparing freshly explanted and cyto-centrifuged cells prior to culture, attachment, and spreading are in progress to test this hypothesis.
There were reduced durations in elevation of the HA-MnSOD transgene product expression in BAM cells and AT-II cells, but the reduction did not correlate with decreased MnSOD biochemical levels detected in whole lung (Table 1 ) (Figure 1 ). This result may be attributable to cell-type-specific differences in deactivation of MnSOD transgene encoded enzyme activity. It is also possible that BAM cells and AT-II cells expressed higher levels of MnSOD than interstitial and endothelial cells, and relative losses of expression in these cell types may have led to greater decreases in total lung MnSOD activity. Further experiments will be required to determine the magnitude of differential expression of the HA-MnSOD transgene in BAM and AT-II cells compared to endothelial and interstitial cells. The data in Table 1 show a decreased differential expression of the HA-MnSOD transgene in BAM and AT-II cells compared to endothelial and interstitial cells. Further investigations utilizing the MnSOD transgene linked to cell phenotype specific promoters will be required to determine whether overexpression of the MnSOD transgene in endothelial and interstitial cells affects the magnitude of overall organ response to ionizing irradiation.
The results presented in this paper demonstrate that all cell types have increased expression of HA-MnSOD at the time of irradiation. No single cell type has preferential expression of MnSOD, which may indicate that it is the target cell. Irradiation damage to this target cell may lead to the development of organizing alveolitis/fibrosis. Immediately following irradiation, and at 100-120 days after irradiation, there is an increase in cytokine expression and changes in endothelial adhesion molecules expression. [3] [4] [5] 8, 9, 11, [26] [27] [28] Damage to endothelial cells may cause changes in adhesion molecule expression, leading to migration of macrophages or fibroblasts to this site of damage and resulting in organizing alveolitis/fibrosis. 8, [26] [27] [28] Increased cytokine expression activates macrophages, which could lead to a release of reactive oxygen species (ROS), damaging other cells and ultimately leading to organizing alveolitis/fibrosis. 29, 30 Irradiation damage to slowly dividing AT-II cells or interstitial cells may not be recognized for 100 days, at which time there is increased cytokine expression, leading to changes in adhesion molecule expression and migration of macrophages and fibroblasts into the damaged region. 8 Protection of the lung from irradiation-induced damage may require increased MnSOD expression in all cell types of the lung since damage to any one cell type may be able to initiate the fibrotic pathway. Future studies using vectors, which can selectively infect specific cell types, will be required to further delineate which cell types are damaged, resulting in the development of organizing alveolitis/fibrosis.
Materials and methods

Mice, irradiation, and histopathology
In present studies, C57BL/6NHsd (Harlan SpragueDawley, Indianapolis, IN, USA) mice were used, while in prior studies we have used C57BL/6J mice (Jackson Laboratories, Bar Harbor, ME, USA). C57BL/6NHsd female mice (25-30 g) were IT injected with HA-MnSOD-PL at doses of 0-1000 mg of plasmid DNA in 75 ml plasmid/liposome complexes. Twenty-four hours later, subgroups of mice received 20 Gy irradiation to both lungs using a Varian 600C Linear Accelerator (Varian Medical Systems, Palo Alto, CA, USA). The mice were shielded so that only the pulmonary cavity was irradiated. Other mice received liposomes, but not plasmid. The mice were killed at 1, 2, 3 or 4 days after injection. The lungs were excised and frozen in liquid nitrogen for either determination of MnSOD biochemical activity or to be used to isolate compartments.
Construction and use of HA-MnSOD epitope-tagged MnSOD
An HA-MnSOD transgene under the control of a CMV promoter was constructed that maintained biochemical activity. The HA tag was present in the pCGN vector prior to cloning in the MnSOD gene. The HA tag was located downstream of the CMV promoter, but located upstream of the multiple cloning site. The MnSOD sequence was inserted into the pCGN vector using a 5 0 XbaI and a 3 0 KpnI site, which was located in the multiple cloning sites. It is present on the MnSOD gene as part of PCR primers. 8 The protein product, therefore, contained an N-terminal HA tag, followed by a mitochondrial localization sequence (intrinsic to the coding sequence), and then by a mature protein at the C-terminal end.
Measurement of MnSOD biochemical activity
Lungs from C3H/HeNsd mice IT injected with 0, 10, 250, 500 or 1000 mg of MnSOD-PL were assayed for MnSOD biochemical activity. 23 Subgroups were irradiated to 20 Gy 24 h after injection. Mice were killed on days 1,2, 3 or 4 following injection. The lungs were excised, frozen in liquid nitrogen, thawed, sonicated, and protein quantitated. Aliquots of 0, 50, 100 or 200 mg protein were incubated in 20 mM PBS, 1 mM diethylenetriamine pentaacetic acid (DEPATAC), 1 U catalase, 5.6 Â 10 À8 M nitroblue tetrazolium (NBT), 0.1 mM xanthine, 0.05 mM bathocuproinedisulfonic acid (BCS), 0.13 mg/ml defatted bovine serum albumin (BSA) and 5 mM sodium cyanide for 45 min at room temperature. 23 Xanthine oxidase (10 À2 M) was added and the change in absorbance at 560 nm as a function of time was measured. In this reaction, superoxides produced by the reaction of xanthine with xanthine oxidase reduced NBT, which resulted in increased absorbance at 550 nm. In the presence of MnSOD, superoxides were converted to H 2 O 2 , thus preventing the reduction of NBT and inhibiting an increase in absorbance. Samples containing higher levels of MnSOD will result in increased inhibition of the calorimetric assay.
Separation of different cellular components of the mouse lung C57BL/6NHsd mice were IT injected with 0, 250 or 500 mg of plasmid DNA and subgroups were irradiated to 20 Gy 24 h later. To isolate different cellular compartments of the lung, mice were killed 1, 2, 3 or 4 days after injection. The pulmonary cavity was opened and lungs profused by injecting 5 ml of phosphate-buffered saline (PBS) into the right ventricle of the heart. BAMs were isolated by IT injection of 1 ml of PBS into the mouse lungs. Twenty seconds later, PBS was removed and BAMs were attached to microscope slides by cytospin. To isolate pulmonary endothelial cells, 8 the lungs were filled with 1 ml of dispase, allowed to collapse, and then expanded with 0.5 ml of a 1% low-melt agarose, which had been stored at 451C in a water bath. The lungs were immediately covered with ice and incubated for 2 min. The lungs were then removed, placed in 2 ml of dispase, incubated for 45 min at room temperature, and placed on ice. The lungs were transferred to 7 ml of Dulbecco's modified Eagle's medium (DMEM) containing 0.01% DNA, then teased away from the airways and swirled for 5-10 min at room temperature. The resulting suspension was filtered through a 40 mm cell strainer, centrifuged at 250 g for 10 min at 41C, and resuspended in 10 ml of DMEM. An anti-platelet endothelial cell adhesion molecule (PECAM) monoclonal antibody attached to dynabeads was added to the cells and incubated for 30 min at 41C with gentle mixing. The tube containing the cells was attached to a magnetic tube separator, and endothelial cells attached to dynabeads were separated from AT-II cells and interstitial cells. The endothelial cells were washed five times in PBS, and the beads were digested from endothelial cells by incubating the beads in 1 ml of trypsin/EDTA for 5 min at 371C. The cells were washed, resuspended, and incubated in a T25 tissue culture flask in 10 ml of DMEM plus 10% FCS overnight. AT-II cells and interstitial cells were separated by resuspending the remaining cells in 10 ml of DMEM. 9, 14 Biotinylated anti-CD 32 (0.65 mg per million cells) and biotinylated anti-CD 4 (1.5 mg per million cells) were added to cells and incubated at 371C for 30 min. The cells were then washed twice, resuspended in 7 ml of DMEM, added to Strepavidin-coated beads, and incubated with gentle rocking for 30 min at room temperature. The tube was attached to a magnetic tube separator, and AT-II cells and interstitial cells were removed from the bottom of the tube, centrifuged, resuspended in DMEM, and incubated overnight in tissue culture treated plates. The nonadherent cells, which contained AT-II cells, were removed and attached to microscope slides by cytospin. The attached cells left after the removal of AT-II cells contained pulmonary interstitial cells. The cells from different cell compartments were fixed in methanol. An assay for expression of HA using a fluoroscein isothiocyanate (FITC) conjugated monoclonal anti-HA antibody was performed as previously described. HA-MnSOD. Subgroups were also irradiated to 20 Gy to the pulmonary cavity on day 1. Day 1 mice from the irradiated mice were killed immediately after irradiation. The different cell types were isolated and stained for expression of HA-MnSOD as described above. Cells were examined under a fluorescent microscope and percent of cells expressing HA calculated. The percent of total lung cells in each cell compartment was based on published data for rat lung. 15 Multiplying the percent of total lung cells in each compartment by the percent of HA-positive cells for each compartment yields the percent of total lung cells positive for HA expression for each cell type. The percent increase in MnSOD activity from each compartment was calculated by dividing the percent of lung cell positive for HA expression for each cell type by the total percent of HA-positive lung cells for that particular day. Total MnSOD biochemical activity was determined as described above. The increase in MnSOD biochemical activity due to expression of HAMnSOD for each was determined by comparing the MnSOD levels following injection with that of control, non-injected mice.
An example as to how these calculations were performed is as follows. For the BAM cells on day 1 of Table 1 
Animal welfare
All protocols were approved by the Institutional Animal Care and Use Committee of the University of Pittsburgh. Veterinary care was provided by the Central Animal Facility of the University of Pittsburgh in strict accordance with the Institutional Animal Care and Use Committee of the University of Pittsburgh guidelines. The mice were housed in SPF conditions in the presence of sentinel mice that were monitored every 3 months for pathogens. All sentinel mice were negative for all pathogens tested, especially for those that cause pneumonitis.
